Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cooperative Economic Partnership Between India And Korea To Narrow Korean Healthcare Trade Deficit

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea and India signed a bilateral Comprehensive Economic Partnership Agreement in Seoul on August 7, under which the Korean government expects to reduce the country's deficit with India in the healthcare sector by $3.2 million for the first five years beginning in 2010

You may also be interested in...



U.S. And South Korean Presidents Say More Negotiation Needed To Ratify Free Trade Agreement But Pharma Provisions Seen Intact

SEOUL - Although South Korean President Lee Myung-bak and U.S. President Barack Obama last week hinted at the possibility of more talks or a partial revision of their bilateral Free Trade Agreement in the U.S. Congress, pharma provisions outlined in the FTA aren't likely to be a bone of contention

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

Latest Headlines
See All
UsernamePublicRestriction

Register

SC072459

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel